Domů › Myelofibróza › New York › New York City
Klinické studie Myelofibróza v New York City, NY
18 studií pro Myelofibróza hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Probíhá náborFáze 1/2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Probíhá náborFáze 3
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Probíhá náborFáze 2
- NYP/Weill Cornell Medical Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Probíhá náborFáze 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Probíhá náborFáze 1
- Icahn School of Medicine At Mount Sinai, New York
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Probíhá náborFáze 2
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Probíhá náborFáze 2
- GSK Investigational Site, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Probíhá náborFáze 1
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Probíhá náborFáze 2
- Memorial Sloan Kettering, New York
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Probíhá náborFáze 2
- Weill Cornell Medicine NewYork-Presbyterian, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Probíhá náborObservační studie
- Memorial Sloan Kettering Cancer Center, New York
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Probíhá náborFáze 2
- Ruttenberg Treatment Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, New York
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Probíhá náborFáze 3
- ICAHN School of Medicine at Mount Sinai, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Probíhá náborFáze 1
- Columbia University, New York
Studie Myelofibróza v jiných městech
- Houston, TX19 studií
- Durham, NC12 studií
- Boston, MA12 studií
- Seattle, WA11 studií
- Columbus, OH11 studií
- Miami, FL10 studií
- Salt Lake City, UT10 studií
- Tampa, FL9 studií
- Atlanta, GA9 studií
- Cleveland, OH9 studií
- Nashville, TN9 studií
- Baldwin Park, CA9 studií
Další studie v New York City
- Rakovina prsu137 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)110 studií
- Rakovina prostaty102 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků70 studií
- Rakovina slinivky břišní60 studií
- Mnohočetný myelom60 studií
- Rakovina plic60 studií
- Rakovina endometria52 studií
- Srdeční selhání51 studií
Zdroj: ClinicalTrials.gov, data načtena 7. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.